
Dianthus Therapeutics, Inc. (DNTH) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Dianthus Therapeutics, Inc..
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerDNTH Technical Analysis Summary
Dianthus Therapeutics, Inc. stock currently shows a bearish trend, weighed down by selling pressure and weak momentum.
This mix signals that Dianthus Therapeutics, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 37.35
Stochastic %K: 27.17
Williams %R: -69.42
Rate of Change (ROC): -13.86
Takeaway:Dianthus Therapeutics, Inc. shows weakening momentum, with sellers gaining the edge.
MACD: -1.68
ADX: 20.75
ATR (14): 5.71
CCI (14): -203.45
Takeaway:Dianthus Therapeutics, Inc. shows oversold trend conditions, with potential for rebound if buyers step in.
Takeaway:Dianthus Therapeutics, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:Dianthus Therapeutics, Inc. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:DNTH shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Dianthus Therapeutics, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.